Company Research

Nomura Code produces a range of research on an extensive list of individual companies reviewing their prospects and providing investment recommendations. Our publications range from in-depth detailed analyses of companies, for example before IPO, through regular updates to ‘flash reports’ reacting quickly to important breaking news.

Nomura Code’s analysts have collectively over 100 years of experience in the life sciences industry. The team includes specialists in biotechnology, pharmaceuticals, healthcare and medical technology. Nomura Code’s analysts include 3 PhD qualified.